生物分析测试服务的全球市场规模、份额和成长分析：按工作流程、按测试 - 产业预测（2024-2031）

Global Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Workflow(Sample Preparation, and Sample Analysis), By Test(ADME, PK) - Industry Forecast 2024-2031

出版日期: 2024年03月28日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

生物分析测试服务的全球市场规模预计在2022年达到24.2亿美元，从2023年的27.8亿美元增长到2031年，预测期内（2024-2031年）复合年增长率为15%。预计将增长到美国2020 年为 85.1 亿美元。

生物分析测试服务市场旨在为製药和生物技术公司提供可靠和精确的测试解决方案，以支持安全有效的药物的开发。全球生物分析测试服务市场的主要驱动因素是对药物开发和监管核准服务的需求不断增长。随着製药和生物技术领域的快速扩张，对可靠、准确的检测服务的需求不断增加。然而，全球生物分析测试服务市场面临的主要挑战是与这些服务相关的高成本。全球生物分析测试服务市场的一个主要障碍与分析方法和程序缺乏标准化有关。不同服务供应商所采用的方法和程序的差异可能会导致结果不一致以及所产生资料的不可靠性。儘管面临这些挑战，全球生物分析测试服务市场为服务供应商提供了许多机会。对个人化医疗和标靶治疗的需求迅速增长，推动了对更专业、更量身定制的检测服务的需求。

Eurofins Scientific SE（Luxembourg）
Charles River Laboratories International, Inc.（USA）
Laboratory Corporation of America Holdings（USA）
WuXi AppTec（China）
PPD, Inc.（USA）
Frontage Laboratories, Inc.（USA）
SGS SA（Switzerland）
ICON plc（Ireland）
Intertek Group plc（UK）
Bioanalytical Systems, Inc.（USA）
Almac Group（UK）
Anapharm（Canada）
Pharmaron Beijing Co., Ltd.（China）
Syneos Health（USA）
Celerion（USA）
BioAgilytix Labs（USA）
Medpace Holdings, Inc.（USA）
LGC Limited（UK）
PSI CRO AG（Switzerland）
Bioclinica（USA）

简介目录

Product Code: SQMIG35D2157

Global bioanalytical testing services market size was valued at USD 2.42 billion in 2022 and is poised to grow from USD 2.78 billion in 2023 to USD 8.51 billion by 2031, at a CAGR of 15 % during the forecast period (2024-2031).

The bioanalytical testing services market aims to deliver dependable and precise testing solutions to pharmaceutical and biotech firms, aiding them in the development of safe and efficacious drugs. The principal driver behind the global bioanalytical testing services market is the escalating demand for drug development and regulatory approval services. As the pharmaceutical and biotech sectors undergo rapid expansion, there is a growing requirement for trustworthy and accurate testing services. However, the primary challenge for the global bioanalytical testing services market is the high cost associated with these services. A significant hurdle in the global bioanalytical testing services market pertains to the lack of standardization in analytical methods and procedures. Divergence in the methodologies and procedures employed by various service providers may result in inconsistent outcomes, thereby jeopardizing the reliability of the generated data. Despite these challenges, the global bioanalytical testing services market presents several opportunities for service providers. The burgeoning demand for personalized medicine and targeted therapies is propelling the necessity for more specialized and tailored testing services.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioanalytical Testing Services Market Segmental Analysis

The global bioanalytical testing services market is segmented based on workflow, test, and region. By workflow, the market is segmented into sample preparation, and sample analysis. By test, the market is segmented into ADME, PK, PD, bioavailability, bioequivalence, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Bioanalytical Testing Services Market

There is a rising demand for personalized medicine, and bioanalytical testing services are pivotal in the development and evaluation of personalized drugs. These tests are instrumental in assessing the efficacy of drugs on individual patients and assist in determining the most suitable treatment regimen for patients. For example, in 2021, Q^2 Solutions, a leading provider of clinical trials laboratory services globally, broadened its biomarker capabilities to bolster the clinical advancement of personalized medicine. This expansion encompassed the establishment of a cutting-edge flow cytometry laboratory in Scotland, UK.

Restraints in the Global Bioanalytical Testing Services Market

An important factor expected to hinder the growth of the bioanalytical testing services market is the scarcity of qualified individuals proficient in operating the sophisticated equipment essential for conducting bioanalytical tests. According to the US Bureau of Labor Statistics, by 2020, there are projected to be 18,580 vacancies in clinical laboratory science (CLS) programs across the nation. However, only approximately 5,000 students complete accredited CLS programs each year. This indicates that educational programs are producing less than one-third of the necessary trained professionals. Consequently, the adoption of new technologies and methodologies may encounter challenges, potentially constraining the market's future growth.

Market Trends of the Global Bioanalytical Testing Services Market

Pharmaceutical companies are progressively turning to third-party service providers to outsource bioanalytical testing services, aiming to cut costs, enhance efficiency, and concentrate on their core strengths. This outsourcing trend is anticipated to persist in the foreseeable future.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Bioanalytical Testing Services Market by Workflow

Market Overview
Sample Preparation
and Sample Analysis

Global Bioanalytical Testing Services Market by Test

Market Overview
ADME
PK
PD
Bioavailability
Bioequivalence
and Others

Global Bioanalytical Testing Services Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioanalytical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anapharm (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron Beijing Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PSI CRO AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioclinica (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments